中华心血管病杂志最新文献

筛选
英文 中文
[Complex congenital heart disease with atrial fibrillation and cerebral infarction in adult: a case report]. [成人复杂先天性心脏病伴心房颤动和脑梗塞:病例报告]。
中华心血管病杂志 Pub Date : 2024-06-24 DOI: 10.3760/cma.j.cn112148-20231019-00345
X Wang, H Z Lu, L J Yang, K Yang
{"title":"[Complex congenital heart disease with atrial fibrillation and cerebral infarction in adult: a case report].","authors":"X Wang, H Z Lu, L J Yang, K Yang","doi":"10.3760/cma.j.cn112148-20231019-00345","DOIUrl":"10.3760/cma.j.cn112148-20231019-00345","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 6","pages":"703-705"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on the treatment of pediatric hypertrophic cardiomyopathy]. [治疗小儿肥厚型心肌病的研究进展]。
中华心血管病杂志 Pub Date : 2024-06-24 DOI: 10.3760/cma.j.cn112148-20231025-00380
L X Chang, J Li, X H Shi, X N Lu, J Wang, S J Ta, L W Liu
{"title":"[Research progress on the treatment of pediatric hypertrophic cardiomyopathy].","authors":"L X Chang, J Li, X H Shi, X N Lu, J Wang, S J Ta, L W Liu","doi":"10.3760/cma.j.cn112148-20231025-00380","DOIUrl":"10.3760/cma.j.cn112148-20231025-00380","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 6","pages":"723-728"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese guidelines for the diagnosis and management of patients with chronic coronary syndrome]. [中国慢性冠脉综合征患者诊治指南]。
中华心血管病杂志 Pub Date : 2024-06-24 DOI: 10.3760/cma.j.cn112148-20240325-00168
{"title":"[Chinese guidelines for the diagnosis and management of patients with chronic coronary syndrome].","authors":"","doi":"10.3760/cma.j.cn112148-20240325-00168","DOIUrl":"10.3760/cma.j.cn112148-20240325-00168","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 6","pages":"589-614"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese expert consensus on the standardized diagnosis and treatment of patent foramen ovale]. [中国专家关于卵圆孔孔径标准化诊断和治疗的共识]。
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20231030-00393
{"title":"[Chinese expert consensus on the standardized diagnosis and treatment of patent foramen ovale].","authors":"","doi":"10.3760/cma.j.cn112148-20231030-00393","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20231030-00393","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 4","pages":"369-383"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prognostic performance of pulmonary effective arterial elastance in patients with heart failure]. [心力衰竭患者肺部有效动脉弹性的预后能力]
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20231120-00449
Y H Wu, B P Huang, J Y Feng, L Y Huang, X M Zhao, J Wang, J Y Guan, X Q Li, Y H Zhang, J Zhang
{"title":"[Prognostic performance of pulmonary effective arterial elastance in patients with heart failure].","authors":"Y H Wu, B P Huang, J Y Feng, L Y Huang, X M Zhao, J Wang, J Y Guan, X Q Li, Y H Zhang, J Zhang","doi":"10.3760/cma.j.cn112148-20231120-00449","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20231120-00449","url":null,"abstract":"<p><p><b>Objective:</b> To explore the predictive value of pulmonary effective arterial elastance (Ea) in patients with heart failure (HF). <b>Methods:</b> This is a retrospective cohort study, which retrospectively included 284 patients with HF who underwent right heart catheterization at Heart Failure Center in Fuwai Hospital between September 2013 and February 2022. Data regarding baseline clinical characteristics, hemodynamic profiles, and prognosis were collected. Ea was calculated as mean pulmonary arterial pressure/stroke volume. Patients were divided into Ea<0.555 group and Ea≥0.555 group according to the median value of Ea (0.555 mmHg/ml, 1 mmHg=0.133 kPa). The primary outcome was the primary clinical event, set as the first occurrence of a series of composite events, including all-cause death, heart transplantation, left ventricular assist device implantation, and HF rehospitalization. Event-free survival was defined as the absence of primary clinical events. Spearman correlation analysis was used to calculate the correlation coefficient between Ea and parameters reflective of right heart function. The Kaplan-Meier analysis was used to compare the different groups for the estimation of outcomes with the log-rank test. We used Cox proportional-hazards regression models to estimate hazard ratios (<i>HR</i>) for primary clinical event. Subgroup analysis was performed based on the age, gender, New York Heart Association (NYHA) functional class, left ventricular ejection fraction, presence of pulmonary hypertension, and serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) values. We used receiver operating characteristic (ROC) curve to calculate the area under the curve (<i>AUC</i>) of Ea for predicting event-free survival in patients with HF. <b>Results:</b> The median age was 51 years, and 206 (72.5%) patients were male. Ea and pulmonary vascular resistance (PVR) were significantly correlated (<i>r</i>=0.698, <i>P<</i>0.001). The correlation between Ea and pulmonary arterial elastance (PAC) were even more significant (<i>r</i>=-0.888, <i>P</i><0.001). Compared with Ea<0.555 group, Ea≥0.555 group presented with higher serum NT-proBNP values (4 443 (1 792, 8 554) ng/L vs. 1 721 (480, 4 528)ng/L,<i>P</i><0.001), higher PVR (3.4 (2.5, 4.7) Wood vs. 1.4 (0.9, 2.2) Wood, <i>P</i><0.001), lower cardiac output (3.0 (2.3, 3.9) L/min vs. 4.3 (3.8, 4.9) L/min, <i>P</i><0.001), and lower PAC (1.6 (1.3, 2.0) ml/mmHg vs. 4.0 (3.0, 6.0) ml/mmHg, <i>P</i><0.001). The median follow-up time was 392 (166, 811) days. The Kaplan-Meier survival curve demonstrated a lower event-free survival rate in the Ea≥0.555 group compared to the Ea<0.555 group (<i>P</i><sub>log-rank</sub><0.001). After multivariate adjustment, Ea (<i>HR</i>=1.734, <i>P</i><0.001) remained significantly associated with the primary outcome. Subgroup analysis indicated that Ea was associated with the primary outcome across all subgroups. The <i>AUC</i> was 0.724 (<i>P</i><0.001) for Ea ","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 4","pages":"397-404"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prioritizing the diagnosis and treatment of cardiac amyloidosis]. [优先诊断和治疗心脏淀粉样变性]。
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20231224-00523
Z Tian, S Y Zhang
{"title":"[Prioritizing the diagnosis and treatment of cardiac amyloidosis].","authors":"Z Tian, S Y Zhang","doi":"10.3760/cma.j.cn112148-20231224-00523","DOIUrl":"10.3760/cma.j.cn112148-20231224-00523","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 4","pages":"327-329"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The prediction value of combined serum levels of TMAO and TML for poor prognosis in patients with heart failure]. [TMAO和TML联合血清水平对心力衰竭患者不良预后的预测价值]。
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20240104-00008
R Xi, Q Fan, R Tao
{"title":"[The prediction value of combined serum levels of TMAO and TML for poor prognosis in patients with heart failure].","authors":"R Xi, Q Fan, R Tao","doi":"10.3760/cma.j.cn112148-20240104-00008","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20240104-00008","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the predictive value of combined serum levels of trimethylamine N-oxide (TMAO) and trimethyllysine (TML) for poor prognosis in patients with heart failure. <b>Methods:</b> This single-center prospective cohort study included hospitalized patients with heart failure and complete baseline data from the Department of Cardiology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from June 2017 to December 2020. Patients were categorized into four groups based on median serum levels of TMAO and TML after admission: TMAO low level TML low level group (TMAO<9.7 μmol/L, TML<0.73 μmol/L), TMAO low level TML high level group (TMAO<9.7 μmol/L, TML≥0.73 μmol/L), TMAO high level TML low level group (TMAO≥9.7 μmol/L, TML<0.73 μmol/L) and TMAO high level TML high level group (TMAO≥9.7 μmol/L, TML≥0.73 μmol/L). The primary endpoint was a composite endpoint of cardiovascular death and readmission for heart failure. Multiple factor Cox regression analysis was conducted to evaluate the correlation between serum TMAO and TML levels and poor prognosis in patients with heart failure. <b>Results:</b> A total of 471 patients with heart failure were included, with an mean age of (62.5±12.0) years and a median follow-up time of 1.61 (1.06, 2.90) years. Multivariate Cox regression analysis showed that after adjusting for age, gender, and traditional risk factors, the TMAO high level TML high level group had a higher incidence of primary endpoint events compared to the TMAO low level TML low level group (<i>HR</i>=1.71, 95%<i>CI</i> 1.05-2.77, <i>P</i>=0.03). <b>Conclusion:</b> Elevated serum levels of both TMAO and TML can effectively predict the occurrence of long-term adverse events in patients with heart failure.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 4","pages":"405-412"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese guideline for lipid management (primary care version 2024)]. [中国血脂管理指南(基层医疗 2024 年版)]。
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20240102-00002
{"title":"[Chinese guideline for lipid management (primary care version 2024)].","authors":"","doi":"10.3760/cma.j.cn112148-20240102-00002","DOIUrl":"10.3760/cma.j.cn112148-20240102-00002","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 ","pages":"330-337"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Successful rescue of postpartum pulmonary hypertension crisis: a multidisciplinary approach in a case report]. [成功挽救产后肺动脉高压危机:病例报告中的多学科方法]。
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20231130-00472
L L Qiu, Y Li, L J Pei, G T Ma, J L Zhao, J G Liu, X Q Xu
{"title":"[Successful rescue of postpartum pulmonary hypertension crisis: a multidisciplinary approach in a case report].","authors":"L L Qiu, Y Li, L J Pei, G T Ma, J L Zhao, J G Liu, X Q Xu","doi":"10.3760/cma.j.cn112148-20231130-00472","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20231130-00472","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 4","pages":"420-424"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese expert consensus statement on the classification and interpretation of variants in genes associated with common inherited cardiovascular diseases]. [关于常见遗传性心血管疾病相关基因变异的分类和解释的中国专家共识声明]。
中华心血管病杂志 Pub Date : 2024-04-24 DOI: 10.3760/cma.j.cn112148-20230916-00167
{"title":"[Chinese expert consensus statement on the classification and interpretation of variants in genes associated with common inherited cardiovascular diseases].","authors":"","doi":"10.3760/cma.j.cn112148-20230916-00167","DOIUrl":"10.3760/cma.j.cn112148-20230916-00167","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 4","pages":"338-368"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信